Dimitrios Chatzis

Dr. Dimitrios Chatzis


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in World Journal of Clinical Cases
Verified
Journal Article
Open access
DCDimitrios Chatzis
Dimitrios Chatzis
KMKalliopi Magounaki
Kalliopi Magounaki
IPIoannis Pantazopoulos
Ioannis Pantazopoulos
SBSonu Menachem Maimonides Bhaskar
Sonu Menachem Maimonides Bhaskar
The current coronavirus disease 2019 (COVID-19) pandemic has had devastating impact on populations around the world. The high mortality rates in patients with COVID-19 has been attributed to the influence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), its causative viral agent, on several physiological systems in human body, including the respiratory, cardiovascular, and neurological systems. There is emerging evidence on propensity of this virus to attack cardiovascular system. However, various pathophysiological mecha nisms by which SARS-CoV-2 interacts with cardiovascular system and leads to high morbidity and mortality, including cardiovascular complications, are poorly understood. This mini review aims to provide an update on the current know ledge and perspectives on areas of future research.

29 September 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
AGAndroniki Gkana
Androniki Gkana
APAndroniki Papadopoulou
Androniki Papadopoulou
Maria MermiriMaria Mermiri
Maria Mermiri
EBEleftherios Beltsios
Eleftherios Beltsios
DCDimitrios Chatzis
Dimitrios Chatzis
Ioannis PantazopoulosIoannis Pantazopoulos
Ioannis Pantazopoulos
Pulmonary embolism (PE) is a rather common cardiovascular disorder constituting one of the major manifestations of venous thromboembolism (VTE). It is associated with high mortality and substantial recurrence rates, and its diagnosis may be challenging, especially in patients with respiratory comorbidities. Therefore, providing a prompt and accurate diagnosis for PE through developing highly sensitive and specific diagnostic algorithms would be of paramount importance. There is sound evidence supporting the use of biomarkers to enhance the diagnosis and predict the recurrence risk in patients with PE. Therefore, several novel biomarkers, such as factor VIII, Ischemia Modified Albumin, and fibrinogen, as well as several MicroRNAs and microparticles, have been investigated for the diagnosis of this clinical entity. The present review targets to comprehensively present the literature regarding the novel diagnostic biomarkers for PE, as well as to discuss the evidence for their use in daily routine.

9 September 2025 in CNS Drugs
Verified
Journal Article
Closed access
PDF file
MGMuskaan Gupta
Muskaan Gupta
ISIvica Smokovski
Ivica Smokovski
DCDimitrios Chatzis
Dimitrios Chatzis
KSKevin Spring
Kevin Spring
MMMan Mohan Mehndiratta
Man Mohan Mehndiratta
Sonu BhaskarSonu Bhaskar
Sonu Bhaskar

1 October 2020 in Minerva Cardiology and Angiology
Verified
Journal Article
Closed access
DCDimitrios Chatzis
Dimitrios Chatzis
KMKalliopi T. Magounaki
Kalliopi T. Magounaki
IPIoannis N. Pantazopoulos
Ioannis N. Pantazopoulos
EJElizabeth O. Johnson
Elizabeth O. Johnson
KTKonstantinos P. Tsioufis
Konstantinos P. Tsioufis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus disease 2019 (COVID-19) which recently has been characterized as a pandemic by the World Health Organization (WHO) having killed almost 250,000 people worldwide as of May 4th, 2020. Despite the fact that SARS-CoV-2 seems to predominantly affect the respiratory system leading to pneumonia and acute respiratory distress syndrome, it is now evident that it may also affect the cardiovascular system in multiple ways. The current paper is a review of the most recent literature regarding SARS-CoV-2 infection and its associated main cardiovascular clinical manifestations. Cardiovascular disease represents a prevalent underlying comorbidity associated with increased mortality rates among COVID-19 affected individuals. In addition, various cardiovascular manifestations have been linked to the viral insult, including among others acute coronary syndromes, myocarditis, acute heart failure, cardiac injury, arrhythmias and acute pulmonary embolism. Further studies are required in order to establish the complicated association between SARS-CoV-2 infection and its effects on the cardiovascular system. Our knowledge regarding diagnostic approaches, therapeutic management and preventive measures is constantly enriched throughout an abundance of ongoing research in the respective fields.

18 March 2023 in Drugs & Aging
Verified
Journal Article
Closed access
PDF file
DCDimitrios Chatzis
Dimitrios Chatzis
KMKalliopi Magounaki
Kalliopi Magounaki
IPIoannis Pantazopoulos
Ioannis Pantazopoulos
EBEleftherios T. Beltsios
Eleftherios T. Beltsios
VKVasiliki Katsi
Vasiliki Katsi
KTKonstantinos P. Tsioufis
Konstantinos P. Tsioufis

10 May 2021 in Archives of Medical Science
Verified
Journal Article
Open access
Sonu BhaskarSonu Bhaskar
Sonu Bhaskar
SJSanja Jovanovic
Sanja Jovanovic
AKAnubhav Katyal
Anubhav Katyal
NNNarayanan K Namboodiri
Narayanan K Namboodiri
DCDimitrios Chatzis
Dimitrios Chatzis
Maciej BanachMaciej Banach
Maciej Banach
Introduction: Obesity has emerged as one of the major risk factors of severe morbidity and cause-specific mortality among severe acute respiratory syndromes coronavirus-2 (SARS-CoV-2) infected individuals. Patients with obesity also have overlapping cardiovascular diseases and diabetes, which...